The global Small Molecule Cancer Drug Market is expected to reach USD 139.37 Biliion by the end of 2032, with a valuation of USD 83.20 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 5.9%. The study examines the factors driving and limiting the global Small Molecule Cancer Drug...